Stock screener

BCYC

Conviction 0HealthcareScan · Mon, Aug 10, 2026
BCYC$4.10-1.68%
ResistanceSupportVol 14Insider sell
63 bars
6
5
Vol MA14 295.46K
May 11May 28Jun 16Jul 6Jul 23Aug 10
BICYCLE THERAPEUTICS PLCPHARMACEUTICAL PREPARATIONSwww.bicycletherapeutics.com ↗
Price4.10
Change-1.68%
Gap+0.84%
Rel volume0.70×
Avg volume284.93K
Avg $ vol1.15M
SMA 204.05
SMA 504.14
SMA 2005.48
Price vs 50-0.88%
Price vs 200-25.16%
MA stackbearish
50/200 cross—
Supertrenddown · 4.36
RSI (14)51
MACD hist0.02
MACD crossbull · 1d
Stoch %K / %D75 / 62
ADX (14)16
+DI / −DI19 / 13
RSI divergence—
MACD divergence—
ATR %+4.03%
ADR %3.77%
52w high8.87
52w low3.86
From 52w high-53.78%
Above 52w low+6.22%
New 52w highNo
SqueezeOff
Bollinger width13.27%
%B0.59
Donchian pos55.91%
Donchian high4.38
Donchian low3.75
AVWAP (52w high)5.35
vs AVWAP high-23.43%
AVWAP (52w low)3.99
vs AVWAP low+2.74%
OBV trendFlat
Chaikin MF (20)-0.09
Today vs 20d0.70×
Avg vol (14d)295.45K
Avg vol (20d)284.93K
Avg $ vol (20d)1.15M
Market cap—
RS 3m (vs SPY)-20.42%
RS 6m (vs SPY)-35.58%
RS line new highNo
Trend template0/8
Technical rank20.2
1 week+5.94%
1 month-7.03%
3 months-14.76%
6 months-27.56%
1 year-45.04%
YTD-38.62%
P/E-0.57
P/B0.25
P/S1.73
P/FCF-0.50
EPS-3.16
Div yield—
ROE-42.91%
ROA-36.10%
Debt/Eq0.06
Current12.08
EV/EBITDA1.47
Gross margin—
Net margin-301.66%
Rev growth105.77%
EPS growth-29.54%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-353.86M
Revenue629K
Net income-50.33M
Gross profit—
Free cash flow-252.03M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out50.37M
Employees288
ListedThu, May 23, 2019
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank20.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.48
Support3.81
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BCYC

All disclosures →
No recent disclosed trades by Congress in BCYC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BCYC · 4 buys · 6 sells

InsiderSideShares
Skynner Michael
CHIEF SCIENTIFIC OFFICER · Employee Stock Option (right to buy) · 2026-07-15
Grant60K
Thompson Travis Alvin
Chief Financial Officer · Employee Stock Option (right to buy) · 2026-07-15
Grant60K
Hannay Michael Charles Ferguson
CHIEF PROD & SUPPLY CHAIN OFF · Employee Stock Option (right to buy) · 2026-07-15
Grant60K
Perry Jennifer Scott
Chief Operating Officer · Employee Stock Option (right to buy) · 2026-07-15
Grant60K
Perry Jennifer Scott
Chief Operating Officer · Ordinary Shares · 2026-07-06
Sell333
Skynner Michael
CHIEF SCIENTIFIC OFFICER · Ordinary Shares · 2026-07-06
Sell532
Lee Kevin
CHIEF EXECUTIVE OFFICER · Ordinary Shares · 2026-07-06
Sell1.74K
Thompson Travis Alvin
Chief Financial Officer · Ordinary Shares · 2026-07-06
Sell104
Hannay Michael Charles Ferguson
CHIEF PROD & SUPPLY CHAIN OFF · Ordinary Shares · 2026-07-06
Sell255
Perry Jennifer Scott
Chief Operating Officer · Ordinary Shares · 2026-07-06
Sell43

SEC filings

EDGAR filings in BCYC · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.